β2-microglobulin-associated regulation of interferon-γ and virus-specific immunoglobulin G confer resistance against the development of chronic coxsackievirus myocarditis

被引:50
作者
Klingel, K [1 ]
Schnorr, JJ [1 ]
Sauter, M [1 ]
Szalay, G [1 ]
Kandolf, R [1 ]
机构
[1] Univ Tubingen Hosp, Inst Pathol, Dept Mol Pathol, D-72076 Tubingen, Germany
关键词
D O I
10.1016/S0002-9440(10)64305-2
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
To gain insight into the strategies of the immune system to confer resistance against the development of chronic coxsackievirus B3 (CVB3) myocarditis we compared the course of the disease in C57BL/6 mice, beta2-microglobulin knockout (beta2m(-/-)) mice, and perform-deficient (perform(-/-)) mice. We found that perforin(-/-) mice as well as immunocompetent C57BL/6 mice reveal a resistant phenotype with complete elimination of the virus from the heart in the course of acute myocarditis. In contrast, myocardial CVB3 infection of beta2m(-/-) mice was characterized by a significantly higher virus load associated with a fiulminant acute inflammatory response and, as a consequence of virus persistence, by the development of chronic myocarditis. Interferon-gamma secretion of stimulated spleen cells was found to be significantly delayed in beta2m(-/-) mice compared to perforin(-/-) mice and C57BL/6 control mice during acute myocarditis. In addition, generation of virus-specific IgG and neutralizing antibodies were found to be significantly decreased in beta2m(-/-) mice during acute infection. From these results we conclude that protection against the development of chronic myocarditis strongly depends on the expression of beta2m, influencing the catabolism of IgG as well as the production of protective cytokines, such as interferon-gamma. Moreover, CVB3-induced cardiac injury and prevention of chronic myocarditis was found to be unrelated to perform-mediated cytotoxicity in our model system.
引用
收藏
页码:1709 / 1720
页数:12
相关论文
共 66 条
[1]  
Andreoletti L, 1997, J MED VIROL, V52, P206, DOI 10.1002/(SICI)1096-9071(199706)52:2<206::AID-JMV15>3.0.CO
[2]  
2-I
[3]   Meta-analysis of the association of enteroviruses with human heart disease [J].
Baboonian, C ;
Treasure, T .
HEART, 1997, 78 (06) :539-543
[4]   A SUBSET OF CD4(+) THYMOCYTES SELECTED BY MHC CLASS-I MOLECULES [J].
BENDELAC, A ;
KILLEEN, N ;
LITTMAN, DR ;
SCHWARTZ, RH .
SCIENCE, 1994, 263 (5154) :1774-1778
[5]   Cardiac failure in transgenic mice with myocardial expression of tumor necrosis factor-α [J].
Bryant, D ;
Becker, L ;
Richardson, J ;
Shelton, J ;
Franco, F ;
Peshock, R ;
Thompson, M ;
Giroir, B .
CIRCULATION, 1998, 97 (14) :1375-1381
[6]  
CHOW LH, 1992, LAB INVEST, V66, P24
[7]  
Christianson GJ, 1997, J IMMUNOL, V159, P4781
[8]   CLASS-I DEPENDENCE OF THE DEVELOPMENT OF CD4+CD8-NK1.1+ THYMOCYTES [J].
COLES, MC ;
RAULET, DH .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (01) :395-399
[9]   The source of early IFN-γ that plays a role in Th1 priming [J].
Das, G ;
Sheridan, S ;
Janeway, CA .
JOURNAL OF IMMUNOLOGY, 2001, 167 (04) :2004-2010
[10]   Apoptosis in cardiac diseases: stress- and mitogen-activated signaling pathways [J].
Feuerstein, GZ ;
Young, PR .
CARDIOVASCULAR RESEARCH, 2000, 45 (03) :560-569